Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

9038.  John Victor T, Malathi M, Guruswamy D, Desai A, Anuradha L, Rani C, Krishnamurthy P ():   Dengue fever outbreaks in two villages of Dharmapuri district in Tamil nadu.  Indian J Med Res 2002; 116(Oct): 133-9.

9039.  Lupi O, Tyring SK. Tropical dermatology: viral tropical diseases. J Am Acad Dermatol. 2003 Dec;49(6):979-1000; quiz 1000-2. Review.

9040.  Oishi K, Inoue S, Cinco MT, Dimaano EM, Alera MT, Alfon JA, Abanes F, Cruz DJ, Matias RR, Matsuura H, Hasebe F, Tanimura S, Kumatori A, Morita K, Natividad FF, Nagatake T. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol. 2003 Oct;71(2):259-64.

Pathogenesis:

9041.  Catteau A, Kalinina O, Wagner MC, Deubel V, Courageot MP, Despres P. Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. J Gen Virol. 2003 Oct;84(Pt 10):2781-93.

9042.  Gubler DJ. Aedes albopictus in Africa. Lancet Infect Dis. 2003 Dec;3(12):751-2.

9043.  Just-Nubling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection. 2003 Oct;31(5):318-23.

9044.  Lo Re V 3rd, Gluckman SJ. Fever in the returned traveler. Am Fam Physician. 2003 Oct 1;68(7):1343-50. Review.

9045.  Raviprakash K, Ewing D, Simmons M, Porter KR, Jones TR, Hayes CG, Stout R, Murphy GS. Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology. 2003 Oct 25;315(2):345-52.

9046.  Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, De Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol. 2003 Nov;77(21):11822-32.

9047.  Wei HY, Jiang LF, Fang DY, Guo HY. Dengue virus type 2 infects human endothelial cells through binding of the viral envelope glycoprotein to cell surface polypeptides. J Gen Virol. 2003 Nov;84(Pt 11):3095-8.

Vaccines:

9048.  Jaiswal S, Khanna N, Swaminathan S. Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2. J Virol. 2003 Dec;77(23):12907-13.

9049.  Raviprakash K, Ewing D, Simmons M, Porter KR, Jones TR, Hayes CG, Stout R, Murphy GS. Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology. 2003 Oct 25;315(2):345-52.

Therapy:

9050.  Sharma DC.  Delays hinder outbreak investigations in India. Lancet Infect Dis. 2003 Oct;3(10):607.

9051. Huang CY, Butrapet S, Tsuchiya KR, Bhamarapravati N, Gubler DJ, Kinney RM.  Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J Virol. 2003 Nov;77(21):11436-47.